Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Giuseppe, Stragliotto"'
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Autor:
Suhas Vasaikar, Giorgos Tsipras, Natalia Landázuri, Helena Costa, Vanessa Wilhelmi, Patrick Scicluna, Huanhuan L. Cui, Abdul-Aleem Mohammad, Belghis Davoudi, Mingmei Shang, Sharan Ananthaseshan, Klas Strååt, Giuseppe Stragliotto, Afsar Rahbar, Kum Thong Wong, Jesper Tegner, Koon-Chu Yaiw, Cecilia Söderberg-Naucler
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Glioblastoma (GBM) is the most common malignant brain tumor with median survival of 12-15 months. Owing to uncertainty in clinical outcome, additional prognostic marker(s) apart from existing markers are needed. Since overexpressi
Externí odkaz:
https://doaj.org/article/eb7a314e54f24c7e91cc8421104d2f9d
Autor:
Eskil Degsell, Sofia Hylin, Giuseppe Stragliotto, Petra Danapfel, Anna Blommengren, John Övretveit
Publikováno v:
International Journal of Integrated Care, Vol 19, Iss 4 (2019)
Most care is provided by patients to themselves and their family. Healthcare systems around the world have been responding to the demand for better organization of models of patient centered integrated care (PCIC). Models of integrated care may enhan
Externí odkaz:
https://doaj.org/article/ebb6a83decc54c5594898b880332649b
Publikováno v:
Microorganisms, Vol 8, Iss 10, p 1471 (2020)
Patients with glioblastoma have a very poor prognosis despite aggressive therapeutic strategies. Cytomegalovirus has been detected in >90% of glioblastoma tumors. This virus can affect tumor progression and may represent a novel glioblastoma therapy
Externí odkaz:
https://doaj.org/article/02db08648dc34b458ee141f3e7850bd6
Publikováno v:
Cancers. 14(8)
Glioblastoma invariably recurs despite aggressive and multimodal first-line treatment and no standardized second-line therapy exists. We previously reported that treatment with the antiviral drug valganciclovir as an add-on to standard therapy signif
Autor:
Giuseppe Stragliotto
Publikováno v:
Case Reports and Images In Oncology. :1-4
Karolinska University Hospital has experience of treating patients with (TTFields, Optune®) since 2014. This case report presents a 22-year-old female patient with diffuse midline glioma, H3-K27M mutated, WHO Grade IV. The tumor was unresponsive to
IntroductionGlioblastoma invariably recurs despite aggressive and multimodal first line treatment and no standardized second line therapy exists. We previously reported that treatment with the antiviral drug valganciclovir as an add-on to standard th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a652c3b1ff369a250969bfec9d43909f
https://doi.org/10.21203/rs.3.rs-1246592/v1
https://doi.org/10.21203/rs.3.rs-1246592/v1
Autor:
Katja Werlenius, Asgeir Store Jakola, Karine N. Dzhandzhugazyan, Malin Blomstrand, Dorte Dyregaard, Bertil Rydenhag, Alexei F. Kirkin, Michael Strandeus, Anja Smits, Helena Carén, Giuseppe Stragliotto, Martin K Raida, Sara Kinhult
Publikováno v:
Neuro-oncology Advances
Background There is an urgent need for effective treatments against glioblastoma (GBM). In this trial, we investigated the efficacy and safety of an adoptive cell-based immunotherapy. Methods Patients with newly diagnosed GBM were recruited at 4 stud
Autor:
Abdul-Aleem Mohammad, Afsar Rahbar, Weng-Onn Lui, Belghis Davoudi, Anca Catrina, Giuseppe Stragliotto, Linda Mellbin, Anders Hamsten, Lars Rydén, Koon-Chu Yaiw, Cecilia Söderberg-Nauclér
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113740 (2014)
BACKGROUND: microRNAs (miRNA) are 18-22 nucleotides long non-coding RNAs that regulate gene expression at a post-transcriptional level. Human cytomegalovirus (HCMV) encodes at least 26 known mature miRNAs. hcmv-miR-UL112-3p (miR-UL112-3p) is the most
Externí odkaz:
https://doaj.org/article/b817d1132f0345c09b1d58c16038dfa1
Autor:
Mattia Russel Pantalone, Giuseppe Stragliotto, Afsar Rahbar, Jiri Bartek, Cecilia Söderberg-Nauclér
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(15)
Purpose: Several groups have reported a prevalence of human cytomegalovirus (CMV) in glioblastoma close to 100%. Previously, we reported that treatment with the antiviral drug valganciclovir as an add-on to standard therapy significantly prolonged su
Autor:
S. Hylin, John Øvretveit, Giuseppe Stragliotto, Petra Danapfel, Anna Blommengren, Eskil Degsell
Publikováno v:
International Journal of Integrated Care, Vol 19, Iss 4 (2019)
International Journal of Integrated Care; Vol 19: Annual Conference Supplement 2019; 157
International Journal of Integrated Care; Vol 19: Annual Conference Supplement 2019; 157
Most care is provided by patients to themselves and their family. Healthcare systems around the world have been responding to the demand for better organization of models of patient centered integrated care (PCIC). Models of integrated care may enhan